United States Human Growth Hormone Drugs Market Report 2018

March 2018 | 98 pages | ID: UE9FB863A32QEN
QYResearch

Abstracts

In this report, the United States Human Growth Hormone Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Human Growth Hormone Drugs in these regions, from 2013 to 2025 (forecast).

United States Human Growth Hormone Drugs market competition by top manufacturers/players, with Human Growth Hormone Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly and Company (US)
• Ferring Holding SA (Switzerland)
• Genentech, Inc. (US)
• GeneScience Pharmaceuticals Co., Ltd. (China)
• Merck KgaA (Germany)
• Novo Nordisk A/S (Denmark)
• Pfizer, Inc. (US)
• Sandoz International GmbH (Germany)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Norditropin
• Genotropin
• Humatrope
• Saizen
• Omnitrope - the Somatropin Biosimilar
• Somatropin Biopartners

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prader-Willi Syndrome
• Turner Syndrome
• Short Stature Homeobox Gene
• Small for Gestational Age
• Chronic Renal Insufficiency
• Short Bowel Syndrome

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Human Growth Hormone Drugs Market Report 2018

1 HUMAN GROWTH HORMONE DRUGS OVERVIEW

1.1 Product Overview and Scope of Human Growth Hormone Drugs
1.2 Classification of Human Growth Hormone Drugs by Product Category
  1.2.1 United States Human Growth Hormone Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Human Growth Hormone Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Norditropin
  1.2.4 Genotropin
  1.2.5 Humatrope
  1.2.6 Saizen
  1.2.7 Omnitrope - the Somatropin Biosimilar
  1.2.8 Somatropin Biopartners
1.3 United States Human Growth Hormone Drugs Market by Application/End Users
  1.3.1 United States Human Growth Hormone Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Prader-Willi Syndrome
  1.3.3 Turner Syndrome
  1.3.4 Short Stature Homeobox Gene
  1.3.5 Small for Gestational Age
  1.3.6 Chronic Renal Insufficiency
  1.3.7 Short Bowel Syndrome
1.4 United States Human Growth Hormone Drugs Market by Region
  1.4.1 United States Human Growth Hormone Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Human Growth Hormone Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Human Growth Hormone Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Human Growth Hormone Drugs Status and Prospect (2013-2025)
  1.4.5 New England Human Growth Hormone Drugs Status and Prospect (2013-2025)
  1.4.6 The South Human Growth Hormone Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Human Growth Hormone Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Human Growth Hormone Drugs (2013-2025)
  1.5.1 United States Human Growth Hormone Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Human Growth Hormone Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES HUMAN GROWTH HORMONE DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Growth Hormone Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Human Growth Hormone Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Human Growth Hormone Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Human Growth Hormone Drugs Market Competitive Situation and Trends
  2.4.1 United States Human Growth Hormone Drugs Market Concentration Rate
  2.4.2 United States Human Growth Hormone Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Growth Hormone Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN GROWTH HORMONE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Human Growth Hormone Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Human Growth Hormone Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Human Growth Hormone Drugs Price by Region (2013-2018)

4 UNITED STATES HUMAN GROWTH HORMONE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Human Growth Hormone Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Human Growth Hormone Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Human Growth Hormone Drugs Price by Type (2013-2018)
4.4 United States Human Growth Hormone Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES HUMAN GROWTH HORMONE DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Human Growth Hormone Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Human Growth Hormone Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN GROWTH HORMONE DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Eli Lilly and Company (US)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Ferring Holding SA (Switzerland)
  6.2.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Genentech, Inc. (US)
  6.3.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 GeneScience Pharmaceuticals Co., Ltd. (China)
  6.4.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Merck KgaA (Germany)
  6.5.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Novo Nordisk A/S (Denmark)
  6.6.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Pfizer, Inc. (US)
  6.7.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Sandoz International GmbH (Germany)
  6.8.2 Human Growth Hormone Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview

7 HUMAN GROWTH HORMONE DRUGS MANUFACTURING COST ANALYSIS

7.1 Human Growth Hormone Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Growth Hormone Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Growth Hormone Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Growth Hormone Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN GROWTH HORMONE DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Human Growth Hormone Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Human Growth Hormone Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Human Growth Hormone Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Human Growth Hormone Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Growth Hormone Drugs
Figure United States Human Growth Hormone Drugs Market Size (K Pcs) by Type (2013-2025)
Figure United States Human Growth Hormone Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Norditropin Product Picture
Figure Genotropin Product Picture
Figure Humatrope Product Picture
Figure Saizen Product Picture
Figure Omnitrope - the Somatropin Biosimilar Product Picture
Figure Somatropin Biopartners Product Picture
Figure United States Human Growth Hormone Drugs Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Human Growth Hormone Drugs by Application in 2017
Figure Prader-Willi Syndrome Examples
Table Key Downstream Customer in Prader-Willi Syndrome
Figure Turner Syndrome Examples
Table Key Downstream Customer in Turner Syndrome
Figure Short Stature Homeobox Gene Examples
Table Key Downstream Customer in Short Stature Homeobox Gene
Figure Small for Gestational Age Examples
Table Key Downstream Customer in Small for Gestational Age
Figure Chronic Renal Insufficiency Examples
Table Key Downstream Customer in Chronic Renal Insufficiency
Figure Short Bowel Syndrome Examples
Table Key Downstream Customer in Short Bowel Syndrome
Figure United States Human Growth Hormone Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Human Growth Hormone Drugs Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Human Growth Hormone Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Human Growth Hormone Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Human Growth Hormone Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Human Growth Hormone Drugs Sales Share by Players/Suppliers
Figure 2017 United States Human Growth Hormone Drugs Sales Share by Players/Suppliers
Figure United States Human Growth Hormone Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Human Growth Hormone Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Human Growth Hormone Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Human Growth Hormone Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Human Growth Hormone Drugs Revenue Share by Players/Suppliers
Table United States Market Human Growth Hormone Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Human Growth Hormone Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Human Growth Hormone Drugs Market Share of Top 3 Players/Suppliers
Figure United States Human Growth Hormone Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Growth Hormone Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Growth Hormone Drugs Product Category
Table United States Human Growth Hormone Drugs Sales (K Pcs) by Region (2013-2018)
Table United States Human Growth Hormone Drugs Sales Share by Region (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Share by Region (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share by Region in 2017
Table United States Human Growth Hormone Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Human Growth Hormone Drugs Revenue Share by Region (2013-2018)
Figure United States Human Growth Hormone Drugs Revenue Market Share by Region (2013-2018)
Figure United States Human Growth Hormone Drugs Revenue Market Share by Region in 2017
Table United States Human Growth Hormone Drugs Price (USD/Pcs) by Region (2013-2018)
Table United States Human Growth Hormone Drugs Sales (K Pcs) by Type (2013-2018)
Table United States Human Growth Hormone Drugs Sales Share by Type (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Share by Type (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share by Type in 2017
Table United States Human Growth Hormone Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Human Growth Hormone Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Human Growth Hormone Drugs by Type (2013-2018)
Figure Revenue Market Share of Human Growth Hormone Drugs by Type in 2017
Table United States Human Growth Hormone Drugs Price (USD/Pcs) by Types (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Growth Rate by Type (2013-2018)
Table United States Human Growth Hormone Drugs Sales (K Pcs) by Application (2013-2018)
Table United States Human Growth Hormone Drugs Sales Market Share by Application (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share by Application (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Market Share by Application in 2017
Table United States Human Growth Hormone Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Human Growth Hormone Drugs Sales Growth Rate by Application (2013-2018)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table Ferring Holding SA (Switzerland) Basic Information List
Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table Genentech, Inc. (US) Basic Information List
Table Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure Genentech, Inc. (US) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information List
Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table Merck KgaA (Germany) Basic Information List
Table Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure Merck KgaA (Germany) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table Novo Nordisk A/S (Denmark) Basic Information List
Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table Sandoz International GmbH (Germany) Basic Information List
Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales Growth Rate (2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales Market Share in United States (2013-2018)
Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Growth Hormone Drugs
Figure Manufacturing Process Analysis of Human Growth Hormone Drugs
Figure Human Growth Hormone Drugs Industrial Chain Analysis
Table Raw Materials Sources of Human Growth Hormone Drugs Major Players/Suppliers in 2017
Table Major Buyers of Human Growth Hormone Drugs
Table Distributors/Traders List
Figure United States Human Growth Hormone Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Human Growth Hormone Drugs Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Human Growth Hormone Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Human Growth Hormone Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Human Growth Hormone Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Human Growth Hormone Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Human Growth Hormone Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources